Antigenic variants of rabies virus

Area of Science:

• Virology
• Immunology
• Vaccinology

Background:

• Rabies virus glycoprotein is a key target for neutralizing antibodies.
• Antigenic variation in rabies virus can affect vaccine efficacy.

Purpose of the Study:

• To investigate the emergence and characteristics of antigenic variants of the rabies virus.
• To assess the impact of these variants on vaccine-induced protection.
• To evaluate current rabies vaccine strain selection and potency testing.

Main Methods:

• Selection of antigenic variants using monoclonal antibodies against rabies virus glycoprotein.
• Neutralization assays to assess variant resistance to antibodies.
• Challenge studies in animals immunized with parent virus or variants.
• Antigenic analysis of vaccine and street rabies virus strains using monoclonal antibodies.

Main Results:

• Selected rabies virus variants resisted neutralization by specific monoclonal antibodies.
• Two distinct antigenic sites were identified through variant analysis.
• Vaccinated animals showed varying protection levels against different virus variants and street strains.
• A closer antigenic relationship was observed between vaccine and challenge strains in protective combinations.

Conclusions:

• Antigenic variation in rabies virus poses a challenge to vaccine efficacy.
• Current methods for selecting rabies vaccine strains and evaluating vaccine potency require revision.
• Further research is needed to understand the role of minor antigenic differences in protective immunity.